Generation of Rag1‐knockout immunodeficient rats and mice using engineered meganucleases

Despite the recent availability of gene‐specific nucleases, such as zinc‐finger nucleases (ZFNs) and transcription activator‐like nucleases (TALENs), there is still a need for new tools to modify the genome of different species in an efficient, rapid, and less costly manner. One aim of this study was to apply, for the first time, engineered meganucleases to mutate an endogenous gene in animal zygotes. The second aim was to target the mouse and rat recombination activating gene 1 (Rag1) to describe, for the first time, Rag1 knockout immunodeficient rats. We microinjected a plasmid encoding a meganuclease for Rag1 into the pronucleus of mouse and rat zygotes. Mutant animals were detected by PCR sequencing of the targeted sequence. A homozygous RAG1‐deficient rat line was generated and immunophenotyped. Meganucleases were efficient, because 3.4 and 0.6% of mouse and rat microinjected zygotes, respectively, generated mutated animals. RAG1‐deficient rats showed significantly decreased proportions and numbers of immature and mature T and B lymphocytes and normal NK cells vs. littermate wild‐type controls. In summary, we describe the use of engineered meganucleases to inactivate an endogenous gene with efficiencies comparable to those of ZFNs and TALENs. Moreover, we generated an immunodeficient rat line useful for studies in which there is a need for biological parameters to be analyzed in the absence of immune responses.—Ménoret, S., Fontanière, S., Jantz, D., Tesson, L., Thinard, R., Rémy, S., Usal, C., Ouisse, L.‐H., Fraichard, A., Anegon, A. Generation of Rag1‐knockout immunodeficient rats and mice using engineered meganucleases. FASEB J. 27, 703–711 (2013). www.fasebj.org

[1]  A. Scharenberg,et al.  Zinc-finger nucleases: a powerful tool for genetic engineering of animals , 2010, Transgenic Research.

[2]  N. Wu,et al.  Production of p53 gene knockout rats by homologous recombination in embryonic stem cells , 2010, Nature.

[3]  P. Duchateau,et al.  Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy , 2011, Current gene therapy.

[4]  Dale L. Greiner,et al.  Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.

[5]  Tadao Serikawa,et al.  Generation of Knockout Rats with X-Linked Severe Combined Immunodeficiency (X-SCID) Using Zinc-Finger Nucleases , 2010, PloS one.

[6]  Michael J. Osborn,et al.  Characterization of immunoglobulin heavy chain knockout rats , 2010, European journal of immunology.

[7]  K. Ono,et al.  Immunological detection of rat heart allograft rejection. , 1972, Transplantation.

[8]  D. Franco,et al.  Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors. , 2009, Current gene therapy.

[9]  Andreu Alibés,et al.  Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases , 2008, Nature.

[10]  Edwin Cuppen,et al.  Progress and prospects in rat genetics: a community view , 2008, Nature Genetics.

[11]  H. Jacob,et al.  Creation and Characterization of a Renin Knockout Rat , 2011, Hypertension.

[12]  I. Thorey,et al.  Efficient Immunoglobulin Gene Disruption and Targeted Replacement in Rabbit Using Zinc Finger Nucleases , 2011, PloS one.

[13]  K. Rodgers,et al.  Putting the pieces together: identification and characterization of structural domains in the V(D)J recombination protein RAG1 , 2004, Immunological reviews.

[14]  H. Jacob,et al.  Generation of gene-specific mutated rats using zinc-finger nucleases. , 2010, Methods in molecular biology.

[15]  L. Hanson,et al.  Characterization of rag1 mutant zebrafish leukocytes , 2009, BMC Immunology.

[16]  Maider Villate,et al.  Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease , 2009, Nucleic acids research.

[17]  Rafael J. Yáñez-Muñoz,et al.  Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases , 2012, Nucleic acids research.

[18]  Ignacio Anegon,et al.  Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases , 2009, Science.

[19]  X. Cui,et al.  Targeted integration in rat and mouse embryos with zinc-finger nucleases , 2011, Nature Biotechnology.

[20]  P. Lowenstein,et al.  Tolerance to Cardiac Allografts Via Local and Systemic Mechanisms After Adenovirus-Mediated CTLA4Ig Expression1 , 2000, The Journal of Immunology.

[21]  David G. Schatz,et al.  The In Vivo Pattern of Binding of RAG1 and RAG2 to Antigen Receptor Loci , 2010, Cell.

[22]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[23]  Elo Leung,et al.  Targeted Genome Editing Across Species Using ZFNs and TALENs , 2011, Science.

[24]  David R. Liu,et al.  Revealing Off-Target Cleavage Specificities of Zinc Finger Nucleases by In Vitro Selection , 2011, Nature Methods.

[25]  A. Fischer,et al.  The mechanisms of immune diversification and their disorders , 2003, Nature Reviews Immunology.

[26]  L Alexander Lyznik,et al.  Heritable targeted mutagenesis in maize using a designed endonuclease. , 2010, The Plant journal : for cell and molecular biology.

[27]  Elo Leung,et al.  Knockout rats generated by embryo microinjection of TALENs , 2011, Nature Biotechnology.

[28]  T. Shinozawa,et al.  Derivation of rat embryonic stem cells and generation of protease-activated receptor-2 knockout rats , 2011, Transgenic Research.

[29]  Lei Zhang,et al.  Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. , 2010, Genome research.

[30]  Zuo Zhang,et al.  Characterization of Multidrug Resistance 1a/P-Glycoprotein Knockout Rats Generated by Zinc Finger Nucleases , 2012, Molecular Pharmacology.